Related Experiment Video
Updated: Jan 1, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Genetics of Alzheimer's disease: where we are, and where we are going
Céline Bellenguez1, Benjamin Grenier-Boley1, Jean-Charles Lambert1
1Univ. Lille, Inserm, Institut Pasteur de Lille, CHU Lille, U1167 - Labex DISTALZ - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, F-59000 Lille, France.
Abstract:
Alzheimer's disease (AD) has a very strong genetic component, whose characterization has become an essential part of efforts to understand the pathophysiological processes of the disease. Thanks to the systematic use of high-throughput approaches over the last 10 years, more than 40 genes/loci have been linked to the AD risk. Although some of these signals are likely to be false positives, this genetic knowledge has shed new light on the pathogenesis of AD and, in particular, the major role of microglia. However, our knowledge of the genetics of AD is far from complete, and larger and more diverse genetic studies are required. Lastly, post-GWAS analyses will be needed to make sense of this genetic information without focusing too much on what we think we know about the disease.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer's Disease: Treatment
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

